Advanced Magnetics moves closer to Combidex approval
This article was originally published in Clinica
Executive Summary
Several years after filing for FDA approval for its metastatic lymph node-detecting MRI agent, Combidex, Advanced Magnetics might be finally set to take the product to the US market. The Cambridge, Massachusetts firm has received another approvable letter from the FDA for the agent.